Molecule partners to develop Web3-based ecosystem addressing inefficiencies in biopharma R&D
Molecule, a biotech IP Web3 marketplace, has announced a tripartite partnership with Apollo Health Ventures, a longevity-focused venture capital fund,…
Pharmaceuticals, Biotechnology and Life Sciences
Molecule, a biotech IP Web3 marketplace, has announced a tripartite partnership with Apollo Health Ventures, a longevity-focused venture capital fund,…
PrecisionLife Limited has appointed Colin Stubberfield, Ph.D. as SVP Drug Discovery. He will be based at the company’s UK headquarters…
Valneva’s subsidiary Valneva Scotland has been awarded research and development funding of up to £20 million by Scottish Enterprise. The…
Recipharm, a global contract development and manufacturing organisation (CDMO), has announced the acquisition of Vibalogics, a virotherapy CDMO and a…
Sandoz has announced the launch of generic oncology medicine lenalidomide, indicated for several haemato-oncology conditions as recommended by the latest…
Intellia Therapeutics, Inc. (NASDAQ:NTLA), a genome editing company focused on developing curative therapies leveraging CRISPR-based technologies, and ONK Therapeutics Ltd.,…
miDiagnostics, a POC diagnostics company backed by Belgian Family Offices, announces the success of the Brussels Airport pilot study for…
The startup company Novel Concepts Medical has announced that its novel plant-based treatment has resulted in successfully inhibiting the COVID-19…
AOP Orphan Pharmaceuticals announced that on Monday February 14, 2022 the German Federal Court of Justice decided on PEC’s challenge…
AstraZeneca’s Saphnelo (anifrolumab) has been approved in the European Union as an add-on therapy for the treatment of adult patients with moderate…